CBD shows early promise for neurodevelopmental disorders in children
Emerging clinical evidence suggests cannabidiol may safely improve symptoms of autism spectrum disorder, intellectual disability, tics, and ADHD in children, though research remains early.
Quick Facts
What This Study Found
CBD modulates the endocannabinoid system in developing brains through multiple mechanisms and appears to have anxiolytic, antipsychotic, and neuroprotective properties. Clinical evidence suggests early CBD treatment could improve common symptoms in neurodevelopmental disorders including social interaction deficits, anxiety, hyperactivity, and sleep problems.
Key Numbers
Review covers four neurodevelopmental disorders: intellectual disability, autism spectrum disorder, tics, and ADHD. CBD described as having a "relatively high toxicity limit."
How They Did This
Literature review of clinical and pre-clinical studies on cannabinoid use in pediatric neurodevelopmental disorders, with attention to safety and efficacy.
Why This Research Matters
Neurodevelopmental disorders affect millions of children and current medications often have significant side effects. CBD offers a potential alternative with a relatively high safety threshold.
The Bigger Picture
The pathophysiology of neurodevelopmental disorders remains only partially understood, making targeted pharmacological treatment difficult. CBD's broad neuromodulatory effects may address multiple symptom domains simultaneously.
What This Study Doesn't Tell Us
Most evidence is preliminary. Limited controlled trials in pediatric populations. Long-term effects of CBD on developing brains need more study.
Questions This Raises
- ?What are the optimal CBD doses for different neurodevelopmental conditions in children?
- ?How does long-term CBD use affect brain development?
Trust & Context
- Key Stat:
- Evidence spans autism, intellectual disability, tics, and ADHD
- Evidence Grade:
- Narrative review drawing on limited clinical studies and preclinical data. Most evidence is early-stage.
- Study Age:
- Published in 2022.
- Original Title:
- The role of cannabinoids in neurodevelopmental disorders of children and adolescents.
- Published In:
- Revista de neurologia, 75(7), 189-197 (2022)
- Authors:
- Dias-de Freitas, F, Pimenta, S, Soares, S, Gonzaga, D, Vaz-Matos, I, Prior, C
- Database ID:
- RTHC-03806
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Which neurodevelopmental disorders showed the most promise?
Autism spectrum disorder had the most emerging evidence, with studies suggesting CBD may improve social interaction, anxiety, hyperactivity, and sleep problems.
Is CBD safe for children?
The review notes CBD has a "relatively high toxicity limit," but emphasizes that long-term safety data in developing brains is still limited and more research is needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03806APA
Dias-de Freitas, F; Pimenta, S; Soares, S; Gonzaga, D; Vaz-Matos, I; Prior, C. (2022). The role of cannabinoids in neurodevelopmental disorders of children and adolescents.. Revista de neurologia, 75(7), 189-197. https://doi.org/10.33588/rn.7507.2022123
MLA
Dias-de Freitas, F, et al. "The role of cannabinoids in neurodevelopmental disorders of children and adolescents.." Revista de neurologia, 2022. https://doi.org/10.33588/rn.7507.2022123
RethinkTHC
RethinkTHC Research Database. "The role of cannabinoids in neurodevelopmental disorders of ..." RTHC-03806. Retrieved from https://rethinkthc.com/research/dias-de-2022-the-role-of-cannabinoids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.